MeSH tree: D02.455.526.728
When I first arrived at the top secret Porton Down laboratory, I was aware of very little about its activities. I knew it was the UK's chemical defense research center and that over the years it had conducted tests with chemical ...
Feb 23, 2025
0
34
A study led by Roswell Park Comprehensive Cancer Center provides new insight into the complex interactions of the "tumor-immune-gut axis," and its role in influencing immunotherapy responses in patients with recurrent ovarian ...
Dec 13, 2024
0
50
A significant number of multiple myeloma patients may have an inherited but previously unrecognized risk of developing the disease—a type of blood cancer that affects plasma cells. That's the finding of a genetic study that ...
Sep 17, 2024
0
49
New research from Memorial Sloan Kettering Cancer Center (MSK) showed giving chemotherapy shortly after a stem cell or bone marrow transplant from a less than perfectly matched donor greatly reduces the chances that the patient ...
Jul 31, 2024
0
27
Cyclophosphamide (CP), a widely used chemotherapeutic and immunosuppressive agent, has significant impacts on reproductive health in both males and females. A review published in the Journal of Exploratory Research in Pharmacology ...
Jul 23, 2024
0
28
EULAR, The European Alliance of Associations for Rheumatology, updated its recommendations for systemic sclerosis (SSc) in 2023. Notably, four new therapies were added that had not been included in 2017—highlighting how fast ...
Jun 14, 2024
0
68
A new treatment approach using an older drug may enable more patients with high-risk blood cancers to receive transplanted stem cells from unrelated, partially matched donors, according to a study conducted by researchers ...
May 24, 2024
0
27
Allogeneic hematopoietic stem-cell transplantation (allo-HSCT) can cure hematopoietic diseases, such as acute myeloid leukemia. Cord blood transplantation (CBT), which accounts for more than one-third of allo-HSCTs in Japan, ...
Jan 24, 2024
0
31
Treatment with bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma associates with poorer treatment outcomes, finds a recent study.
Dec 19, 2023
0
41
New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, shows that patients with refractory juvenile systemic sclerosis improved significantly on nearly all measures for two years ...
Nov 10, 2023
0
72
